By

Dr Michael Rhodes

Senior Product & Applications Manager

Abstract:

The amazing growth in the capabilities of Sequencing Platforms has outstripped Moores law over the past few years, both in terms of increases in throughput and decreases in cost of sequencing. Life Technologies is the world’s leading sequencing company and has a complete portfolio of sequencing solutions from a single capillary machine through to ultra high throughput sequencing, with single molecule solutions available soon. The SOLiD 4 system generates up to 100 gigabases of mapped data in a single run, some of the applications successfully carried out on the SOLiD system include: Complete cancer genome re-sequencing, single cell transcriptome analysis, Methylation and de Novo sequencing. The latest applications will be presented including results and data analysis and automation solutions. The SOLiD instrument is For Research Use Only, and is not intended for any animal or human therapeutic or diagnostic use